Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Engineering of selective TIMPs.

H Nagase1, Q Meng, V Malinovskii

  • 1Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City 66160, USA. hnagase@kumc.edu

Annals of the New York Academy of Sciences
|July 23, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5).

The Journal of biological chemistry·2001
Same author

Enhanced mu-opioid responses in the spinal cord of mice lacking protein kinase Cgamma isoform.

The Journal of biological chemistry·2001
Same author

The novel kappa-opioid receptor agonist TRK-820 suppresses the rewarding and locomotor-enhancing effects of morphine in mice.

Life sciences·2001
Same author

[Structural analysis for psychosocial factors including health locus of control (HLC) and sense of coherence (SOC) associated with lifestyle-related diseases].

Nihon eiseigaku zasshi. Japanese journal of hygiene·2001
Same author

Involvement of central, but not placental corticotropin releasing hormone (CRH) in heat stress induced immunosuppression during pregnancy.

Brain, behavior, and immunity·2001
Same author

Epistatic interactions between skin tumor modifier loci in interspecific (spretus/musculus) backcross mice.

Cancer research·2001
Same journal

Multiomics Profiling During Autoimmune Demyelination Highlights a Complex Regulatory Role for Ataxin-1 in B Cells.

Annals of the New York Academy of Sciences·2026
Same journal

Global Trends in Light Pollution and Their Relationship With Socioeconomic Factors.

Annals of the New York Academy of Sciences·2026
Same journal

Wired for Corruption: Inter-Brain Synchrony Encodes Bribery-Related Value Information and Predicts Bribery Agreement.

Annals of the New York Academy of Sciences·2026
Same journal

LM-YOLO: A Lightweight Multi-Scale Enhanced Model for Forest Smoke Detection Using Unmanned Aerial Vehicles.

Annals of the New York Academy of Sciences·2026
Same journal

Polyrhythm Perception and Production: A Scoping Review.

Annals of the New York Academy of Sciences·2026
Same journal

DARTS-CNN-BiLSTM: Intelligent Fault Diagnosis for Computer Numerical Control Machine Tool Feed System.

Annals of the New York Academy of Sciences·2026
See all related articles

The N-terminal domain of Tissue Inhibitor of Metalloproteinases-1 (N-TIMP-1) binds to Matrix Metalloproteinases (MMPs) via its second residue. Altering this residue significantly impacts N-TIMP-1

Area of Science:

  • Biochemistry
  • Structural Biology
  • Molecular Biology

Background:

  • Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) regulates Matrix Metalloproteinases (MMPs).
  • Previous studies suggested residues near the Cys1-Cys70 disulfide bond in TIMP-1 interact with MMPs.
  • The precise binding mechanism of TIMP-1 to MMPs, particularly at the N-terminus, requires further elucidation.

Purpose of the Study:

  • To investigate the role of the N-terminal residues of TIMP-1 in MMP binding.
  • To determine the structural basis for the interaction between TIMP-1 and MMP-3.
  • To assess the impact of substitutions at residue 2 of TIMP-1 on its affinity for various MMPs.

Main Methods:

  • X-ray crystallography to determine the structure of the TIMP-1 catalytic domain of MMP-3 complex.

Related Experiment Videos

  • Site-directed mutagenesis to generate N-TIMP-1 variants with amino acid substitutions at residue 2.
  • Affinity measurements of N-TIMP-1 variants for MMPs-1, -2, and -3.

    • Main Results:

    • The crystal structure revealed that the alpha-amino group of Cys1 chelates the catalytic zinc of MMP-3, and the Thr2 side chain occupies the S1' pocket.
    • Mutagenesis of Thr2 in N-TIMP-1 demonstrated that the nature of the side chain at residue 2 critically affects binding affinity for MMPs-1, -2, and -3.
    • The binding mode of N-TIMP-1 residue 2 differs from the P1' residue binding of peptide substrates.

    Conclusions:

    • Residue 2 of N-TIMP-1 plays a crucial role in the interaction with MMPs.
    • The N-terminus of TIMP-1 engages with MMPs through a distinct binding mode compared to peptide substrates.
    • Understanding this interaction provides insights into the inhibitory mechanism of TIMP-1 and can inform the design of novel MMP inhibitors.